Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
Hyperprolactinemia can be a complication of conventional neurolepics as well as risperidone. We report the third case of attenuation of risperidone-induced hyperprolactinemia by aripiprazole.
Rainka
M M
MM
Dent Neurologic Institute, University at Buffalo, Buffalo, NY, USA. mrainka@dentinstitute.com
Capote
H A
HA
Ross
C A
CA
Gengo
F M
FM
D000068180:Aripiprazole; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D018967:Risperidone / Q000009:adverse effects*
D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D000068180:Aripiprazole; D018967:Risperidone